Literature DB >> 33586344

Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years.

Songbo Li1,2, Hui Chen1,3, Jinyu Man4, Tongchao Zhang4, Xiaolin Yin4, Qiufeng He4, Xiaorong Yang1,2,3, Ming Lu1,3,4.   

Abstract

BACKGROUND: Nearly half of the cases of esophageal cancer in the world were in China, but the corresponding burden in China has not been estimated for the past decades or for the near future.
METHODS: Data on the incidence, mortality, and disability-adjusted life years (DALYs) rates owing to esophageal cancer in China from 1990 to 2017 were extracted from the Global Burden of Disease Study 2017. To reflect the trend in the disease burden, we calculated the estimated annual percentage change (EAPC) in the age-standardized rates of these three outcomes in China from 1990 to 2017.
RESULTS: The age-standardized incidence rate (ASIR) for esophageal cancer decreased from 19.38/100,000 in 1990 to 12.23/100,000 in 2017, with an EAPC of -2.53 (95%CI: -2.90, -2.16), but the number of cases of esophageal cancer increased from 164,473 to 234,624. The age-standardized rates of esophageal cancer in females were always lower than they were in males during the study period, and there was a downward trend that was more pronounced among females than males. The most common risk factors for males were smoking and alcohol consumption, while the most common risk factors for females were a diet low in fruits and a high body mass index (BMI). New cases of, and deaths from esophageal cancer are predicted to increase by about 1.5 times in the coming 25 years.
CONCLUSION: Although the age-standardized burden of esophageal cancer has been declining, the number of new cases of, and deaths from esophageal cancer have increased in China over the past 30 years, and they will continue to increase in the near future. Hence, national policies should be adopted to promote the prevention and management of known risk factors for it, especially smoking and excessive caloric intake.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  disease burden; esophageal cancer; prediction; risk factors; trend

Mesh:

Year:  2021        PMID: 33586344      PMCID: PMC7940228          DOI: 10.1002/cam4.3775

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  42 in total

1.  Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.

Authors:  Zhonghu He; Zhen Liu; Mengfei Liu; Chuanhai Guo; Ruiping Xu; Fenglei Li; Anxiang Liu; Haijun Yang; Lin Shen; Qi Wu; Liping Duan; Xiang Li; Chaoting Zhang; Yaqi Pan; Hong Cai; Yang Ke
Journal:  Gut       Date:  2018-01-06       Impact factor: 23.059

2.  Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors.

Authors:  Goodarz Danaei; Stephen Vander Hoorn; Alan D Lopez; Christopher J L Murray; Majid Ezzati
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

3.  Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors.

Authors:  L M Brown; R Hoover; D Silverman; D Baris; R Hayes; G M Swanson; J Schoenberg; R Greenberg; J Liff; A Schwartz; M Dosemeci; L Pottern; J F Fraumeni
Journal:  Am J Epidemiol       Date:  2001-01-15       Impact factor: 4.897

4.  Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China.

Authors:  Wen-Qiang Wei; Zhi-Feng Chen; Yu-Tong He; Hao Feng; Jun Hou; Dong-Mei Lin; Xin-Qing Li; Cui-Lan Guo; Shao-Sen Li; Guo-Qing Wang; Zhi-Wei Dong; Christian C Abnet; You-Lin Qiao
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

5.  Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption.

Authors:  Nirmala Pandeya; Catherine M Olsen; David C Whiteman
Journal:  Cancer Epidemiol       Date:  2013-07-02       Impact factor: 2.984

6.  Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013.

Authors:  Minghuan Wang; Xiang Luo; Shabei Xu; Wenhua Liu; Fengfei Ding; Xiaoxiang Zhang; Liang Wang; Jian Liu; Jianping Hu; Wei Wang
Journal:  Lancet Respir Med       Date:  2018-10-25       Impact factor: 30.700

7.  [Descriptive analysis of incidence and time trends of esophageal and gastric cancers in Linzhou city].

Authors:  Xi-Bin Sun; Zhi-Cai Liu; Shu-Zheng Liu; Bian-Yun Li; Di-Xin Dai; Pei-Liang Quan; Lan-Ping Cheng; Jian-Bang Lu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2007-10

8.  Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer: A Population-Based Cohort Study.

Authors:  Canqing Yu; Haijing Tang; Yu Guo; Zheng Bian; Ling Yang; Yiping Chen; Aiyu Tang; Xue Zhou; Xu Yang; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Ann Intern Med       Date:  2018-02-06       Impact factor: 25.391

9.  A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.

Authors:  Farhad Islami; Hossein Poustchi; Akram Pourshams; Masoud Khoshnia; Abdolsamad Gharavi; Farin Kamangar; Sanford M Dawsey; Christian C Abnet; Paul Brennan; Mahdi Sheikh; Masoud Sotoudeh; Arash Nikmanesh; Shahin Merat; Arash Etemadi; Siavosh Nasseri Moghaddam; Paul D Pharoah; Bruce A Ponder; Nicholas E Day; Ahmedin Jemal; Paolo Boffetta; Reza Malekzadeh
Journal:  Int J Cancer       Date:  2019-03-20       Impact factor: 7.316

10.  Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China.

Authors:  Lihua Hu; Xiao Huang; Chunjiao You; Juxiang Li; Kui Hong; Ping Li; Yanqing Wu; Qinhua Wu; Zengwu Wang; Runlin Gao; Huihui Bao; Xiaoshu Cheng
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

View more
  17 in total

1.  Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma.

Authors:  Xin Li; Xinyu Su; Chen Yan; Yuanyuan Ma; Heng Li; Jianhong Xia; Hongliang Li; Qian Jiang; Liqing Zhou; Zhengyun Zou
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-29       Impact factor: 4.553

2.  Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA.

Authors:  Xiaorong Yang; Hui Chen; Shaowei Sang; Hao Chen; Lanbo Li; Xiaoyun Yang
Journal:  Front Public Health       Date:  2022-05-26

3.  Relationship between postoperative complications of esophageal cancer surgery and season: a retrospective study.

Authors:  Xianben Liu; Kun Gao; Wenqun Xing; Zongfei Wang; Haibo Sun; Yan Zheng
Journal:  Ann Transl Med       Date:  2022-04

4.  Spatiotemporal trends in burden of uterine cancer and its attribution to body mass index in 204 countries and territories from 1990 to 2019.

Authors:  Songbo Li; Hui Chen; Tongchao Zhang; Rongrong Li; Xiaolin Yin; Jinyu Man; Qiufeng He; Xiaorong Yang; Ming Lu
Journal:  Cancer Med       Date:  2022-02-13       Impact factor: 4.711

5.  circHIPK3 regulates cell proliferation and migration by sponging microRNA-124 and regulating serine/threonine kinase 3 expression in esophageal squamous cell carcinoma.

Authors:  Da Yao; Shengcheng Lin; Size Chen; Zhe Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea.

Authors:  Na Liu; Da-Wei Yang; Yan-Xia Wu; Wen-Qiong Xue; Dan-Hua Li; Jiang-Bo Zhang; Yong-Qiao He; Wei-Hua Jia
Journal:  BMC Cancer       Date:  2022-07-29       Impact factor: 4.638

7.  Serum Total Bile Acids in Relation to Gastrointestinal Cancer Risk: A Retrospective Study.

Authors:  Songbo Li; Xiaodong Qu; Luyao Zhang; Na Wang; Min Chen; Xingyu Zhao; Jie Wang; Huanhuan Lv; Ying Qi; Lifeng Zhang; Junye Liu; Yongquan Shi
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

8.  Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma.

Authors:  Shixian Liu; Lei Dou; Kaixuan Wang; Zhao Shi; Ruixue Wang; Xiaohong Zhu; Zehua Song; Shunping Li
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

9.  Comparison of tumor-associated and nontumor-associated esophageal mucosa microbiota in patients with esophageal squamous cell carcinoma.

Authors:  Baihua Zhang; Qin Xiao; Huahai Chen; Tao Zhou; Yeshi Yin
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

10.  Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma.

Authors:  Ning Zhang; Yiwen Liu; Hong Yang; Mengxia Liang; Xiaopeng Wang; Min Wang; Jinyu Kong; Xiang Yuan; Fuyou Zhou
Journal:  Pathol Oncol Res       Date:  2021-07-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.